Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
03/2012
03/29/2012WO2012039972A1 Pharmaceutical composition
03/29/2012WO2012039347A1 Metal complex, light emitting element, and display device
03/29/2012WO2012038392A1 Process for preparing substituted n-phenylhydroxylamines
03/29/2012US20120077806 Deubiquitinase Inhibitors and Methods for Use of the Same
03/29/2012US20120077796 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
03/29/2012CA2806121A1 Pharmaceutical composition
03/28/2012EP2433632A1 Compositions and combinations comprising non-racemic 2-amino-1-(4-chloro-phenyl)-1-[4-(1H-pyrazol-4-yl)-phenyl]-ethanol, for use in medicine
03/28/2012EP2432774A2 Compounds, compositions and methods for modulating uric acid levels
03/28/2012EP2432760A1 Bridged spiro [2.4]heptane derivatives as alx receptor and/or fprl2 agonists
03/28/2012EP1682537B1 Modulators of cellular adhesion
03/28/2012EP1308438B9 3-substituted urea derivatives and medicinal use thereof
03/28/2012CN1997363B Resistance-repellent retroviral protease inhibitors
03/28/2012CN102395558A Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
03/28/2012CN102391222A Novel hydroxamates as therapeutic agents
03/28/2012CN102391184A Synthesis method of celecoxib
03/28/2012CN101646654B Indozalyl sulphonamide derivatives useful as glucocorticoid modulators
03/27/2012US8143425 Heterocyclic aromatic compounds useful as growth hormone secretagogues
03/27/2012US8143424 Thyroid like compounds
03/27/2012US8143302 Methods and compositions for diagnostic and therapeutic targeting of COX-2
03/27/2012US8143287 Thrombopoietin mimetics
03/27/2012CA2524898C 6-arylmethyl-substituted pyrazolopyrimidines
03/27/2012CA2447091C Methods for the treatment and prevention of pain using stress-activated protein kinase
03/22/2012WO2012037411A2 Estrogen receptor modulators and uses thereof
03/22/2012WO2012037410A2 Estrogen receptor modulators and uses thereof
03/22/2012WO2012034403A1 Fluoromethoxypyrazole anthranilamide compounds, synthesization methods and uses thereof
03/22/2012WO2012016314A9 Arachidonic acid-derived coxib analogue-substituted compounds for use in treating pain
03/22/2012US20120071666 Method for Purifying a Pyrazolinone Derivative
03/22/2012US20120071535 Estrogen receptor modulators and uses thereof
03/22/2012US20120071516 Compounds that modulate intracellular calcium
03/22/2012US20120071503 Positive allosteric modulators of group ii mglurs
03/22/2012US20120071475 Urea derivatives having pi3k-inhibiting activity
03/22/2012CA2810094A1 Estrogen receptor modulators and uses thereof
03/21/2012EP2430000A2 Fungicide pyrazole carboxamides derivatives
03/21/2012EP2429999A1 Process for purification of 1-methylpyrazole-4-carboxylic acid esters
03/21/2012EP2429998A1 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
03/21/2012CN1922148B Pyrazole derivatives as protein kinase modulators
03/21/2012CN102388022A Hydrazide compound and use of the same in pest control
03/21/2012CN102382102A Amide compound
03/21/2012CN102382056A Preparation method of 5-hydroxyl-substituted pyrazole
03/21/2012CN102382055A Method for synthetizing 1, 3-diaryl-4-halogen pyrazole compound
03/21/2012CN102382054A Parazole and isoxazole derivative, preparation method for same and application thereof
03/21/2012CN101838239B Pyrazole compound as well as composition and application thereof
03/21/2012CN101801384B Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
03/21/2012CN101687800B Glucokinase activator
03/21/2012CN101466694B Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
03/21/2012CN101466374B Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1(VR1) receptors
03/20/2012US8138368 Process for producing acrylonitrile compound
03/20/2012US8138217 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide
03/20/2012US8138216 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
03/20/2012US8138208 Aminotetrahydroindazoloacetic acids
03/20/2012US8138119 Alkoxyalkyl spirocyclic tetramic acids and tetronic acids
03/20/2012CA2396277C Condensed azepines as vasopressin agonists
03/15/2012WO2012033736A1 Novel piperazine analogs as broad-spectrum influenza antivirals
03/15/2012WO2012031383A1 Amide compounds
03/15/2012WO2012012307A9 Sulfonyl compounds which modulate the cb2 receptor
03/15/2012US20120065407 Process for purification of 1-methylpyrazole-4-carboxylic acid esters
03/15/2012US20120065247 Modulating ires-mediated translation
03/15/2012US20120065239 Process for the production of amides
03/15/2012US20120065191 Pharmaceutical compounds
03/15/2012US20120065173 Chemical compounds
03/15/2012US20120065164 Fungicide pyrazole carboxamides derivates
03/15/2012US20120064032 Novel hydroxamates as therapeutic agents
03/15/2012US20120060926 Polymerizable fullerene derivative and their use in organic photovoltaic cells
03/15/2012CA2809624A1 Novel piperazine analogs as broad-spectrum influenza antivirals
03/14/2012EP2428507A2 Cannabinoid receptor ligands
03/14/2012EP2427436A1 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
03/14/2012EP2427435A1 Substituted phenylureas and phenylamides as vanilloid receptor ligands
03/14/2012EP2427426A1 Insecticidal compounds
03/14/2012EP1147104B1 Aromatic heterocyclic compounds as antiinflammatory agents
03/14/2012CN102372675A 6-chlorine-4-iodine indazole, preparation method and application thereof
03/14/2012CN102372674A Synthesis method for pharmaceutical intermediate 3-formyl-4-halogeno pyrazole
03/14/2012CN102372532A Palladium-catalyzed ortho-orientation nitrification method of aza calixarene compounds
03/14/2012CN101044119B Process for the preparation of pyrazoles
03/13/2012US8134012 A carboxamide such as N-[2-(1,3-dimethylbutyl)phenyl]-2-iodobenzamide or 5-fluoro-1,3-dimethyl-N-[2-(1,3,3-trimethylbutyl)phenyl]-1H-pyrazole-4-carboxamide in combination with tolclofos-methyl and/or flutolanil; use against phytopathogenic fungi; treating transgenic plants or seeds
03/13/2012US8133851 Heteroaroyl-substituted serine amides
03/08/2012WO2012031298A2 Ethynylbenzene derivatives
03/08/2012WO2012030922A1 Fungicidal pyrazoles
03/08/2012WO2012029942A1 Cyclic amide derivative
03/08/2012WO2012029032A2 Heterocyclic compounds as dgat1 inhibitors
03/08/2012WO2012028676A1 New compounds, pharmaceutical compositions and uses thereof
03/08/2012WO2012028629A1 2 - (benzyloxy) benzamides as lrrk2 kinase inhibitors
03/08/2012WO2012028582A1 Herbicidally active ketosultams and diketopyridines
03/08/2012WO2012028563A1 Bace inhibitors for use in the treatment of diabetes
03/08/2012WO2012007877A3 N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels
03/08/2012WO2011139765A3 Compounds that modulate intracellular calcium
03/08/2012US20120059163 Non-linear opticaly active molecules, their synthesis, and use
03/08/2012US20120058893 Herbicidally active ketosultams and diketopyridines
03/08/2012CA2810130A1 Heterocyclic compounds as dgat1 inhibitors
03/08/2012CA2809492A1 Herbicidally active ketosultams and diketopyridines
03/08/2012CA2809112A1 Cyclic amide derivative
03/07/2012EP2426112A1 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates
03/07/2012EP2426111A1 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms
03/07/2012EP2426110A1 Pyrazolyl acrylonitrile compounds and uses thereof
03/07/2012EP2424840A1 Cxcr3 receptor antagonists
03/07/2012EP1727803B1 Processes for preparing substituted n-aryl-n'-[3-(1h-pyrazol-5-yl)phenyl] ureas and intermediates thereof
03/07/2012EP1352650B1 Inhibitors against the production and release of inflammatory cytokines
03/06/2012US8129391 N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof
03/06/2012US8129372 Compounds having NPY Y5 receptor antagonistic activity
03/01/2012WO2012027261A1 Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes
03/01/2012WO2012025473A1 Cc.chemokine receptor 4 antagonists
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 256